ABIOMED INC (ABMD)
US0036541003 - Common Stock
ABIOMED INC
NASDAQ:ABMD (12/21/2022, 7:15:55 PM)
After market: 381.3 +0.28 (+0.07%)381.02
+0.23 (+0.06%)
Company Profile
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company is headquartered in Danvers, Massachusetts and currently employs 2,003 full-time employees. The firm develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The firm's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.
Company Info
ABIOMED INC
22 Cherry Hill Dr
Danvers MASSACHUSETTS 01923
P: 19787775410.0
CEO: Michael R. Minogue
Employees: 2003
Website: https://www.abiomed.com/
ABMD News
a year ago - The Motley FoolIs It Too Late to Buy Johnson & Johnson's Stock?This healthcare juggernaut's recent quarterly results prove just how strong its business is.
a year ago - The Motley Fool2 Best Buffett Stocks to Buy for the Long HaulBoth of these stocks look like bargains right now.
a year ago - Seeking AlphaJNJ stock dips as it closes Abiomed acquisition (NYSE:JNJ)Johnson & Johnson (JNJ) said Thursday it completed the acquisition of cardiac pump maker Abiomed (ABMD) following an M&A agreement the company announced in early November
a year ago - Abiomed, Inc.FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
a year ago - The Motley FoolInterest Rate Hikes Won't Stop These 2 Cash-Rich Growth StocksEven if interest rates go up, you likely won't need to worry about these stocks.
a year ago - The Motley FoolThe Best Stocks to Invest $20,000 in Right NowThe investments you make now could power your portfolio returns for years to come.
ABMD Twits
Here you can normally see the latest stock twits on ABMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
